Related references
Note: Only part of the references are listed.Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Autoantibodies in Experimental Autoimmune Myasthenia Gravis
Alejandro M. Gomez et al.
JOURNAL OF IMMUNOLOGY (2011)
Lactobacillus casei enhances type II collagen/glucosamine-mediated suppression of inflammatory responses in experimental osteoarthritis
Jae-Seon So et al.
LIFE SCIENCES (2011)
Antibody effector mechanisms in myasthenia gravis-Pathogenesis at the neuromuscular junction
Alejandro M. Gomez et al.
AUTOIMMUNITY (2010)
A Novel Probiotic Mixture Exerts a Therapeutic Effect on Experimental Autoimmune Encephalomyelitis Mediated by IL-10 Producing Regulatory T Cells
Shahram Lavasani et al.
PLOS ONE (2010)
Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders
Ho-Keun Kwon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis
Lili Mu et al.
IMMUNOLOGY (2009)
Silencing rapsyn in vivo decreases acetylcholine receptors and augments sodium channels and secondary postsynaptic membrane folding
Pilar Martinez-Martinez et al.
NEUROBIOLOGY OF DISEASE (2009)
Treatment of myasthenia gravis by preventing acetylcholine receptor modulation
Mario Losen et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial
Marc G. H. Besselink et al.
LANCET (2008)
Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor
Hwa-Jung Yi et al.
MOLECULAR IMMUNOLOGY (2008)
Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions
Jae-Seon So et al.
MOLECULAR IMMUNOLOGY (2008)
Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis
Jae-Seon So et al.
MOLECULAR IMMUNOLOGY (2008)
Tolerogenic dendritic cells and the quest for transplant tolerance
Adrian E. Morelli et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Tolerogenic dendritic cells and regulatory T cells: A two-way relationship
Karsten Mahnke et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2007)
Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4+ CD45RBhigh T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation
Namju Kim et al.
CLINICAL IMMUNOLOGY (2007)
Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients
M. Lorea Baroja et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells
Wei Wang et al.
JOURNAL OF IMMUNOLOGY (2007)
Myasthenia gravis: past, present, and future
Bianca M. Conti-Fine et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis
M. A. Zocco et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis
T. Kuehbacher et al.
GUT (2006)
Probiotics and their fermented food products are beneficial for health
S. Parvez et al.
JOURNAL OF APPLIED MICROBIOLOGY (2006)
Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse
F Calcinaro et al.
DIABETOLOGIA (2005)
Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome
M Viljanen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin
HH Smits et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Increased ratio of rapsyn to ACh receptor stabilizes postsynaptic receptors at the mouse neuromuscular synapse
OL Gervásio et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
Immunosuppression of rat myasthenia gravis by oral administration of a syngeneic acetylcholine receptor fragment
PK Maiti et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis
T Mimura et al.
GUT (2004)
Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis
B Sheil et al.
GUT (2004)
Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice
N Ostlie et al.
JOURNAL OF IMMUNOLOGY (2003)
Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients
P Pochard et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production
CS Deng et al.
JOURNAL OF IMMUNOLOGY (2002)
Tumor necrosis factor receptor p55 and p75 deficiency protects mice from developing experimental autoimmune myasthenia gravis
E Goluszko et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18
SH Im et al.
FASEB JOURNAL (2001)
Selective enhancement of systemic Th1 immunity in immunologically immature rats with an orally administered bacterial extract
LM Bowman et al.
INFECTION AND IMMUNITY (2001)
Probiotics in primary prevention of atopic disease:: a randomised placebo-controlled trial
M Kalliomäki et al.
LANCET (2001)
Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria
M Rescigno et al.
NATURE IMMUNOLOGY (2001)
Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravis
HB Wang et al.
INTERNATIONAL IMMUNOLOGY (2000)
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
P Gionchetti et al.
GASTROENTEROLOGY (2000)
Absence of IFN-γ or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice
PI Karachunski et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
